82
Views
14
CrossRef citations to date
0
Altmetric
Pcos

Association of polycystic ovary syndrome with cardiovascular risk factors

, , , &
Pages 47-53 | Received 16 Feb 2009, Accepted 22 Jun 2009, Published online: 11 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

A. T. Ali & F. Guidozzi. (2020) Midlife women’s health consequences associated with polycystic ovary syndrome. Climacteric 23:2, pages 116-122.
Read now

Articles from other publishers (13)

Yani Ke, Kaihan Wu & Shan Liu. (2022) Commentary: Cardiovascular risk according to body mass index in women of reproductive age with polycystic ovary syndrome: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine 9.
Crossref
Banafsheh Yalameha, Hamid Reza Nejabati & Mohammad Nouri. (2022) Circulating microparticles as indicators of cardiometabolic risk in PCOS. Clinica Chimica Acta 533, pages 63-70.
Crossref
Chenchen Zhuang, Xufei Luo, Wenjuan Wang, Runmin Sun, Miaomiao Qi & Jing Yu. (2022) Cardiovascular Risk According to Body Mass Index in Women of Reproductive Age With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine 9.
Crossref
Mohammed Altigani Abdalla, Najeeb Shah, Harshal Deshmukh, Amirhossein Sahebkar, Linda Östlundh, Rami H. Al-Rifai, Stephen L. Atkin & Thozhukat Sathyapalan. (2022) Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. Therapeutic Advances in Endocrinology and Metabolism 13, pages 204201882211271.
Crossref
Valeria Calcaterra, Elvira Verduci, Hellas Cena, Vittoria Carlotta Magenes, Carolina Federica Todisco, Elisavietta Tenuta, Cristina Gregorio, Rachele De Giuseppe, Alessandra Bosetti, Elisabetta Di Profio & Gianvincenzo Zuccotti. (2021) Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility. Nutrients 13:6, pages 1848.
Crossref
Mohammed Altigani Abdalla, Harshal Deshmukh, Stephen Atkin & Thozhukat Sathyapalan. (2020) A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome. Therapeutic Advances in Endocrinology and Metabolism 11, pages 204201882093830.
Crossref
Muhammad Bilal, Abdul Haseeb & Abdur Rehman. (2018) Relationship of Polycystic Ovarian Syndrome with Cardiovascular Risk Factors. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12:3, pages 375-380.
Crossref
Márcio Augusto Pinto de Ávila, Ricardo Vasconcellos Bruno, Fábio Cuiabano Barbosa, Felipe Cupertino de Andrade, Adriana Cardoso de Oliveira e Silva & Antonio Egídio Nardi. (2014) Polycystic ovary syndrome: implications of metabolic dysfunction. Revista do Colégio Brasileiro de Cirurgiões 41:2, pages 106-110.
Crossref
Ning Zhou & Weiping Li. (2012) Increased arterial stiffness in mildly-hypertensive women with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology Research 38:1, pages 349-349.
Crossref
S. L. Mumford, E. F. Schisterman, A. M. Siega-Riz, A. J. Gaskins, A. Z. Steiner, J. L. Daniels, A. F. Olshan, M. L. Hediger, K. Hovey, J. Wactawski-Wende, M. Trevisan & M. S. Bloom. (2010) Cholesterol, endocrine and metabolic disturbances in sporadic anovulatory women with regular menstruation. Human Reproduction 26:2, pages 423-430.
Crossref
Irene Lambrinoudaki. (2011) Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome. Maturitas 68:1, pages 13-16.
Crossref
Kate A Marsh, Katharine S Steinbeck, Fiona S Atkinson, Peter Petocz & Jennie C Brand-Miller. (2010) Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome. The American Journal of Clinical Nutrition 92:1, pages 83-92.
Crossref
Mohammed Altigani Abdalla, Najeeb Shah, Harshal Deshmukh, Linda Östlundh & Thozhukat Sathyapalan. (2021) The Effectiveness of Metformin in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.